Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹4,853.52Admitted-Finance RIO RANGRAT OLD AIR FIELD ROAD BUDAM KASHMIR PIN 190007 J K | BUDGAM | JAMMU AND KASHMIR | 190007 | ₹4,853.52 | L1 | Admitted-Finance |
| 2 | L2₹33,271.90+₹28,418.38 (585.5%)Admitted-Finance 1003 1005 VISHAL TOWER DISTRICT CENTRE JANAK PURI NEW DELHI DELHI 110058 | WEST DELHI | DELHI | 110058 | ₹33,271.90+₹28,418.38 (585.5%) | L2 | Admitted-Finance |
| 3 | L3₹68,553.45+₹63,699.93 (1312.4%)Admitted-Finance | ₹68,553.45+₹63,699.93 (1312.4%) | L3 | Admitted-Finance |
| 4 | L4₹1.6 L+₹1.6 L (3233.1%)Admitted-Finance S 2 GROUND FLOOR OKHLA INDUSTRIAL AREA PHASE II NEW DELHI DELHI 110020 | SOUTH EAST DELHI | DELHI | 110020 | ₹1.6 L+₹1.6 L (3233.1%) | L4 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Gagan Associates L1 | SRI SAI AGENCIES L3 | SMPL Life Sciences Pvt. Ltd. L2 | Medikon India Private Limited L4 |
|---|---|---|---|---|---|---|---|
| 1.00Dept of Hematology | |||||||
| 1.01 | Inj Eculizumab 300mg | 15 | VIAL | - | 65,289 ₹68,553.45 Lowest | - | - |
| 2.01 | Dasatinib 70mg tab | 960 | No | - | - | 16.5 ₹17.32 Lowest | - |
| 3.01 | EHL recombinanat factor VIII 1000 IU | 57 | VIAL | - | - | - | 15,500 ₹16,275 Lowest |
| 4.01 | Inj Anti-Hemophilic 1500UNI ( Factor-VIII) | 225 | PFS | - | - | - | - |
| 5.01 | Recombinant Factor VIII 500 Iu (Human Plasma/Albumin free+ Viral inactivation through solvent detergent treatment step) | 630 | Vial. | - | - | 14,544.97 ₹15,272.22 Lowest | - |
| 6.01 | Vancomycin 250 mg Cap | 700 | No | - | - | 36.7 ₹38.54 Lowest | - |
| 7.01 | Tab Letermovir 480 mg | 300 | No | 2,629.8 ₹2,761.29 Lowest | - | - | - |
| 8.01 | Tab Letermovir 240 mg | 200 | No | 1,992.6 ₹2,092.23 Lowest | - | - | - |
| 9.01 | Melphalan propylene glycol free IP 50mg Injection | 70 | VIAL | - | - | 889.35 ₹933.82 Lowest | - |
Tender Value
₹1.3 Cr
EMD Value
₹6.4 L
Closing Date
19 Mar 2026, 6:00 pmClosed
THE COMMANDANT ARMY HOSPITAL R AND R
THE COMMANDANT ARMY HOSPITAL R AND R DELHI CANTT
2433/MS/EXP/D 1048, 290/38/Hematology(Drugs)/IFA RE-129/2025-26 FOR AHRR
2026_ARMY_754503_1
2433/MS/EXP/D 1048, 290/38/Hematology(Drugs)/IFA RE-129/2025-26
Open Tender
Medical Equipments/Waste
Buy
ARMY HOSPITAL R AND R DELHI CANTT
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹6.4 L
Yes
6 May 2026
27 Feb 2026
20 Mar 2026
27 Feb 2026
19 Mar 2026
27 Feb 2026
27 Feb 2026 - 19 Mar 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1Dept of Hematology | |||||
| 1.01 | Inj Eculizumab 300mg | 15 | VIAL | - | - |
| 2.01 | Dasatinib 70mg tab | 960 | No | - | - |
| 3.01 | EHL recombinanat factor VIII 1000 IU | 57 | VIAL | - | - |
| 4.01 | Inj Anti-Hemophilic 1500UNI ( Factor-VIII) | 225 | PFS | - | - |
| 5.01 | Recombinant Factor VIII 500 Iu (Human Plasma/Albumin free+ Viral inactivation through solvent detergent treatment step) | 630 | Vial. | - | - |
| 6.01 | Vancomycin 250 mg Cap | 700 | No | - | - |
| 7.01 | Tab Letermovir 480 mg | 300 | No | - | - |
| 8.01 | Tab Letermovir 240 mg | 200 | No | - | - |
| 9.01 | Melphalan propylene glycol free IP 50mg Injection | 70 | VIAL | - | - |
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.58 MB
RFP.pdf
Tender Documents • 1.26 MB
BOQ_845078.xls
BOQ • 0.87 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .